A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.

Completed · Phase 1

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

This study will investigate the safety and tolerability of inhaled doses of GSK233705 with a new formulation.

Key facts

Study ID

NCT00453687

Run by

GlaxoSmithKline

People needed

12

Starts

2007-03-09

Expected to finish

2007-05-16

Last updated by the study team

2017-08-07

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy male subjects 18-55 years old
• Non-Smokers

You may not qualify if…

• Any subject with breathing problems.
• High blood pressure and heart abnormalities.
• Any subjects currently taking prescription and non-prescription medications.

Where it is running

• GSK Investigational Site — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.